TRIN
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 12.37K | $212,178 | n/a | −1 |
| Q2 2026 | 52 | +2 | 12.13M | $216.92M | +4 | −3 |
| Q1 2026 | 52 | +1 | 9.66M | $142.07M | +7 | −6 |
| Q4 2025 | 51 | 0 | 9.41M | $137.94M | n/a | n/a |
| Q3 2025 | 11 | 0 | 3.43M | $53.13M | +1 | −1 |
| Q2 2025 | 8 | -1 | 1.51M | $21.27M | +1 | −2 |
| Q1 2025 | 8 | +1 | 1.59M | $24.18M | +2 | −1 |
| Q4 2024 | 7 | 0 | 1.40M | $20.29M | n/a | n/a |
| Q3 2024 | 6 | +1 | 1.23M | $16.63M | +1 | n/a |
| Q2 2024 | 5 | n/a | 609.05K | $8.61M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 252.59K | n/a | $3.57M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 196.12K | n/a | $2.77M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Two Sigma Investments ✦ | 130.35K | n/a | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 15.54K | n/a | $219,792 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 14.44K | n/a | $204,224 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 163 holders, 21.50M shares, $285.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · CEO, President and CIO · 2.30K sh @ 18.04 · $41,424
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology